jeudi 6 avril 2017
Provinces spent $43M on preemie drug experts say can be made for a fraction of the cost
CBC News takes an in-depth look at Synagis, a potentially life-saving drug for premature babies that is so expensive, doctors must tightly control the infection protection, giving it to only the sickest infants.
Related Posts:
'In complete distress': deaf man dies without help in hospital as Canadian Hearing Society strike drags on- 'The enemy of my enemy is my friend:' Couple turns to virus to beat back superbug
- Pharmacare advocates hope Ontario plan will push Trudeau to act
- Glyphosate labels to change, Health Canada announces
- Patient advocate 'deeply disappointed' budget won't cover cancer meds taken at home
Articles
0 comments:
Enregistrer un commentaire